Phytochemical Name : Oridonin

Properties Information
PhytoCAT-ID PhytoCAT-955
Phytochemical name or plant extracts Oridonin
PMID 23746196
Literature evidence These new analogues obtained by rationally modifying the natural product have been demonstrated not only to significantly induce the apoptosis and suppress growth of triple-negative MDA-MB-231 breast cancer both in vitro and in vivo but also effective against drug-resistant ER-positive MCF-7 clones.
IUPAC name NA
Phytochemicals’ class or type of plant extracts Diterpenoid
Source of phytochemicals or plant Extracts Isodon rubescens
Geographical availability China North-Central, China South-Central, China Southeast
Plant parts NA
Other cancers Breast cancer
Target gene or protein Bcl-2, Caspase 3, PARP, AKT
Gene or Protein evidence The results showed that oridonin exhibited a significant effect in inducing apoptosis of MDA-MB-231 cells, enhancing intracellular ROS level, down-regulating expression of Bcl-2 protein, and promoting cleavage of caspase-3 and its substrate PARP. Oridonin binds to AKT1 and potentially functions as an ATP-competitive AKT inhibitor.
Target pathways Ras/Raf/ERK signal pathway Integrin β1/FAK pathway HIF-1α/VEGF signaling pathway PI3K/AKT signaling
IC50 NA
Potency Moreover, oridonin also inhibited tumor invasion and metastasis in vitro possibly via decreasing the expression of MMPs and regulating the Integrin β1/FAK pathway in MDA-MB-231 cells.
Cell line/ mice model MDA-MB-231 , MCF-7, A375-S2
Additional information  CONCLUSION: Our results suggest that the inhibitive effect of oridonin is likely to be driven by the inhibition of Notch signaling pathway and the resulting increased apoptosis.
PubChem ID 5321010
Additional PMIDs 29844859 17251686 25491140 29580806 15008459 23336515 28579904 30008931 28165738 32853925
Additional sources of information https://powo.science.kew.org/taxon/urn:lsid:ipni.org:names:915158-1
Safety NA